跳至主要内容
临床试验/JPRN-UMIN000016034
JPRN-UMIN000016034已完成未知

Effect of tadalafil on bladder blood flow in patients with lower urinary tract symptoms secondary to benign prostate hyperplasia - Effect of tadalafil on bladder blood flow

Department of Urology, Kyorin University School of Medicine0 个研究点目标入组 50 人开始时间: 2015年12月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1. patients with overactive bladder symptoms (OABSS: Q3 2points or more and total score 3 points or more) 2. patients who developed urinary retention in the past 12 months 3. patients strongly suspected of prostate cancer 4. patients with indwelling urethral catheter or intermittent self-catheterization 5. patients with acute urinary tract infection 6. patients with mechanical abnormality of lower urinary tract (eg. urethral stricture, bladder tumor and bladder stone) 7. patients without desire to void 8. patients with uncontrolled hypertension 9. patients with severe heart disease, renal dysfunction or liver dysfunction 10. patients tadalafil is contraindicated 11. patients who have been determined to be unsuitable as a subject by a physician

研究者

发起方
Department of Urology, Kyorin University School of Medicine

相似试验